CClinicalTrials.gg
Status unknownNCT05524558Updated Sep 1, 2022

Assessment of the Hemodynamic Effects of PEEP According to Alveolar Recruitment During the ARDS

An observational study in ARDS, Human, Ventilation Therapy; Complications and Alveolar; Disorder, sponsored by Bicetre Hospital. Status unknown at 1 site in France. Open to participants aged 18 Years and older. Per ClinicalTrials.gov, last updated 2022-09-01.

Sponsored by Bicetre Hospital · Observational

The sponsor has not verified this record recently (last verified Aug 2022), so the status shown — last known as Recruiting — may be out of date.
Study type
Observational
Model
Cohort
Time perspective
Prospective
Enrollment
34
Ages
18 Years and older
Sex
All
01

Study summary

The corner stone of the treatment of ARDS is mechanical ventilation with high levels of positive end-expiratory pressure, also called PEEP. A high level of PEEP is recommended and frequently used. But PEEP can lower cardiac output and contribute to circulatory failure during mechanical ventilation. Nevertheless, in theory, the PEEP-induced pulmonary vascular resistance (PVR) increase could depend on the level of alveolar recruitment, but it has never been proven. Thus, the aim of this study is to determine the relation between the high-PEEP induced PVR and the alveolar recruitment or overdistension.

Read the detailed description

During acute respiratory distress syndrome (ARDS) the application of positive end-expiratory pressure (PEEP) prevents expiratory alveolar collapse. However, it can induce a predominant recruitment effect or, on the contrary, alveolar overdistension. The recruitment/overdistension ratio can be easily assessed using R/I ratio (or recruitment-to-inflation ratio). However, PEEP is likely to lower cardiac output and contribute to the cardiovascular failure that often occurs in patients with ARDS. Among its hemodynamic effects, PEEP is likely to increase pulmonary vascular resistance and, thus, right ventricular afterload. In theory, this effect should only occur if PEEP over-distends the lung volume, compressing the "extra-alveolar" vessels and increasing their resistance. However, this different effect of PEEP on pulmonary vascular resistance depending on the degree of recruitment or overdistension has never been demonstrated during ARDS in humans.

We retrospectively studied data collected from patients with ARDS, monitored by pulmonary artery catheter (PAC), to eventually find a correlation between the high PEEP-induced PVR increase and recruitement/overdistension profile.

02

Conditions studied

  • ARDS, Human
  • Ventilation Therapy; Complications
  • Alveolar; Disorder
03

In context

Respiratory Distress Syndrome

1,597 studies on the registry are indexed under Respiratory Distress Syndrome; 312 are open to participants now.

This study's planned enrollment of 34 is below the median of 100 across 540 observational studies indexed under Respiratory Distress Syndrome.

Browse Respiratory Distress Syndrome studies →

Lead sponsor

Bicetre Hospital is the lead sponsor of 25 studies on the registry; 6 are open to participants now.

Counted across the registry records on this site, refreshed daily.

04

Who can participate

Ages eligible
18 Years and older
Sexes eligible
All
Sampling method
Non-probability sample

Study population

Mechanically ventilated patients over the age of 18, exhibiting ARDS and with a PAC-monitoring already in place.

Inclusion criteria

  • ARDS diagnosed
  • Invasive mechanical ventilation
  • Pulmonary artery catheter already in place
  • Esophagal pressure measure

Exclusion criteria

Exclusion Criteria:

  • Pregnancy
  • Prone position at inclusion
  • Legal protection measures
05

Study design

Observational model
Cohort
Time perspective
Prospective
Enrollment
34 participants (estimated)
Patient registry
No

Interventions

  • DevicePulmonary artery catheter

    PAC already in place

  • DeviceEsophagal pressure

    Esophagal pressure already in place

06

What researchers measure

Primary outcomes

  1. Correlation between PVR and recruitment-to-inflation ratio

    PVR collected at two levels of PEEP and the R/I ratio to assess a relationship between the two variables

    Time frame: Up to hospital discharge (maximum : day 60)

Secondary outcomes

  1. Relationship between the R/I ratio and blood gas analysis

    Data collected from the daily blood samples, to assess a relationship between R/I and arterial oxygen pressure

    Time frame: Up to hospital discharge (maximum : day 60)

  2. Relationship between the R/I ratio and respiratory system compliance

    Ventilatory parameters collected at two levels of PEEP and R/I collected every day to assess a correlation between R/I and lung compliance

    Time frame: Up to hospital discharge (maximum : day 60)

  3. Relationship between right ventricle size and R/I ratio

    Echocardiographic data collected at two levels of PEEP and R/I collected every day to assess a relationship between R/I and changes in RV surface.

    Time frame: Up to hospital discharge (maximum : day 60)

  4. Relationship between PVR change and Transpulmonary gradient (TPG) according to R/I

    Data collected from PAC and R/I measure every day to assess the relationship between R/I and TPG at two levels of PEEP.

    Time frame: Up to hospital discharge (maximum : day 60)

07

Study locations

1 of 1 sites recruiting
  • Bicetre Hospital
    Le Kremlin-Bicêtre, Ile-de-France 94270, France
    Recruiting
08

References and documents

Publications

  • Michard F, Chemla D, Richard C, Wysocki M, Pinsky MR, Lecarpentier Y, Teboul JL. Clinical use of respiratory changes in arterial pulse pressure to monitor the hemodynamic effects of PEEP. Am J Respir Crit Care Med. 1999 Mar;159(3):935-9. doi: 10.1164/ajrccm.159.3.9805077. PubMed 10051276 ↗
  • GUYTON AC, LINDSEY AW, ABERNATHY B, RICHARDSON T. Venous return at various right atrial pressures and the normal venous return curve. Am J Physiol. 1957 Jun;189(3):609-15. doi: 10.1152/ajplegacy.1957.189.3.609. No abstract available. PubMed 13458395 ↗
  • Goldberg HS, Rabson J. Control of cardiac output by systemic vessels. Circulatory adjustments to acute and chronic respiratory failure and the effect of therapeutic interventions. Am J Cardiol. 1981 Mar;47(3):696-702. doi: 10.1016/0002-9149(81)90557-9. No abstract available. PubMed 7008571 ↗
  • Potkin RT, Hudson LD, Weaver LJ, Trobaugh G. Effect of positive end-expiratory pressure on right and left ventricular function in patients with the adult respiratory distress syndrome. Am Rev Respir Dis. 1987 Feb;135(2):307-11. doi: 10.1164/arrd.1987.135.2.307. PubMed 3544983 ↗
  • WHITTENBERGER JL, McGREGOR M, BERGLUND E, BORST HG. Influence of state of inflation of the lung on pulmonary vascular resistance. J Appl Physiol. 1960 Sep;15:878-82. doi: 10.1152/jappl.1960.15.5.878. No abstract available. PubMed 13784949 ↗
  • ARDS Definition Task Force; Ranieri VM, Rubenfeld GD, Thompson BT, Ferguson ND, Caldwell E, Fan E, Camporota L, Slutsky AS. Acute respiratory distress syndrome: the Berlin Definition. JAMA. 2012 Jun 20;307(23):2526-33. doi: 10.1001/jama.2012.5669. PubMed 22797452 ↗
  • Chen L, Del Sorbo L, Grieco DL, Junhasavasdikul D, Rittayamai N, Soliman I, Sklar MC, Rauseo M, Ferguson ND, Fan E, Richard JM, Brochard L. Potential for Lung Recruitment Estimated by the Recruitment-to-Inflation Ratio in Acute Respiratory Distress Syndrome. A Clinical Trial. Am J Respir Crit Care Med. 2020 Jan 15;201(2):178-187. doi: 10.1164/rccm.201902-0334OC. PubMed 31577153 ↗
  • Monnet X, Marik PE, Teboul JL. Prediction of fluid responsiveness: an update. Ann Intensive Care. 2016 Dec;6(1):111. doi: 10.1186/s13613-016-0216-7. Epub 2016 Nov 17. PubMed 27858374 ↗
  • Cecconi M, De Backer D, Antonelli M, Beale R, Bakker J, Hofer C, Jaeschke R, Mebazaa A, Pinsky MR, Teboul JL, Vincent JL, Rhodes A. Consensus on circulatory shock and hemodynamic monitoring. Task force of the European Society of Intensive Care Medicine. Intensive Care Med. 2014 Dec;40(12):1795-815. doi: 10.1007/s00134-014-3525-z. Epub 2014 Nov 13. PubMed 25392034 ↗
09

Updates

Tracking since Sep 25, 2026
No changes since tracking began. The registry record was last updated on Sep 1, 2022, before this site started recording changes on Sep 25, 2026. Its history is on ClinicalTrials.gov ↗
10

Registry details

Key details

Study ID
NCT05524558
Lead sponsor
Bicetre Hospital
Responsible party
Xavier Monnet (Professor, Bicetre Hospital) — Principal investigator
First posted
Sep 1, 2022
Start date
Feb 1, 2022
Primary completion
Sep 2022 (estimated)
Completion
Nov 2022 (estimated)
Last update
Sep 1, 2022

Study contacts

Xavier Monnet, Pr
Contact
xavier.monnet@aphp.fr
01 45 21 35 39

Oversight

Data monitoring committee
No
FDA-regulated drug
No
FDA-regulated device
No
View the source record on ClinicalTrials.gov ↗

Not currently enrolling

This study is status unknown, as verified in Aug 2022. You cannot join it, but the record below documents what was studied.

Follow this study

Get an email when the registry record changes — status, dates, results — or when someone posts here.

Sign in to follow

Discussion

Questions and observations about this study, from anyone following it. Not medical advice, and not a channel to the study team — their contact details are on the registry record.

Sign in to join the discussion. Reading takes no account; posting does. You choose a display name, and a pseudonym is the default.

Nothing here yet. If you are running this trial, taking part in it, or weighing whether to, this is the place to say so.

Start the discussion